| | | | | May 14, 2012 | Ellanse Press Release | | | | 
Utrecht, the Netherlands – AQTIS Medical™ BV, is proud to announce that the Ellansé™ dermal filler Family has received market approval for Australia. This milestone represents a major step forward in the geographical coverage of the product line, and is expected to have an additional impact on the company’s growth.
The Australian aesthetics market is one of the larger markets in Asia Pacific. This market approval provides access to the Ellansé™ dermal filler Family for both practitioners and patients in order to experience the added value of this unique dermal filler.
AQTIS Medical™ is delighted to have received this approval and is confident that together with its local distribution partner, Device Technologies Australia, Ellansé™ will soon be a well-recognized, valued product in the region. | | | | Other News Sections | |
 | | |
